Sevoflurane vs. Propofol: Depression Risk in Anesthesia

Study Highlights Anesthetic-Related Depression Risks

A recent multinational cohort study, published on May 14, 2026, in an unknown Tier 1 venue, has revealed a potential link between the use of sevoflurane anesthesia and an increased risk of long-term depression. Conducted using the TriNetX Global Federated Network data from 2005 to 2024, the study compared outcomes between sevoflurane and propofol, involving 37,936 patients. Researchers found a significant association between sevoflurane exposure and new-onset depression, with an adjusted hazard ratio (aHR) of 1.51, indicating a 51% increased risk compared to propofol.

Mechanisms and Context

The study's findings align with preclinical evidence suggesting that volatile anesthetics like sevoflurane may induce neuroinflammation and oxidative stress, both of which are implicated in depression pathophysiology. In contrast, propofol is known for its neuroprotective properties. This pharmacological distinction may explain the observed differences in psychiatric outcomes. The study's design included a one-year latency washout and excluded patients with preexisting depression, ensuring that the results reflect the impact of anesthetic choice rather than preexisting conditions.

Implications for Clinical Guidelines

The findings underscore the importance of considering neuropsychiatric outcomes when selecting anesthetics. Current clinical guidelines may need to be revisited to incorporate these considerations, particularly for patients at risk of depression. The study suggests that repeated exposures to sevoflurane could further increase depression risk, highlighting the need for careful anesthetic planning in surgical procedures.

Risks and Unknowns

While the study presents compelling evidence, it also raises several questions. The exact biological mechanisms underlying the increased depression risk remain unclear, necessitating further mechanistic studies. Additionally, the study's observational nature means that causality cannot be definitively established. Prospective studies are needed to confirm these findings and explore potential interventions to mitigate risks.

Looking Forward

This research opens new avenues for understanding the long-term psychiatric effects of anesthetics. As the medical community continues to explore these implications, future studies could focus on identifying patient populations most at risk and developing strategies to minimize adverse outcomes. The integration of psychiatric assessments into preoperative evaluations could become a standard practice, ensuring comprehensive care for surgical patients.